key: cord-0989771-p65xc6ma
authors: Magnani, Elena; Mattei, Luca; Paolucci, Elisa; Magalotti, Giovanni; Giacalone, Nicoletta; Praticò, Chiara; Praticò, Beniamino; Zani, Maria Cristina
title: Lung Ultra-Sound in Severe COVID-19 Pneumonia: beyond the diagnostic purpose. A tool to help clinical management in the Sub-Intensive Care Unit
date: 2020-11-27
journal: Respir Med Case Rep
DOI: 10.1016/j.rmcr.2020.101307
sha: 5839904650cbb716f1f152795fe3415290d3f40f
doc_id: 989771
cord_uid: p65xc6ma

Lung Ultra-Sound (LUS) can be very helpful at the diagnostic stage of COVID-19 pneumonia. We describe four clinical cases that summarize other helpful employment of LUS during the management of severe COVID-19 pneumonia with lung failure. LUS, together with clinical signs and arterial blood gases values, assists in guiding prompt clinical management of potential worsening of conditions. The monitoring of size and signs of aeration of consolidations is an important adjuvant in evaluating clinical evolution. The monitoring of LUS patterns can guide the management of non-invasive ventilation as well as the timing of CPAP weaning.

COVID-19 disease can evolve into a severe form with acute hypoxemic lung failure [1] , about a week after illness onset [2] . The management of this phase is based on its early detection, administration of antiviral therapy (e.g. Remdesivir®) and/or immunomodulatory therapies (with cytokines inhibitors -e.g. Tocilizumab®-and steroids) [3] , and on an optimal respiratory support, preferring non-invasive ventilation but not delaying the invasive support when required [4] . Lung Ultra-Sound (LUS) was already known to be helpful and accurate in diagnosing pneumonic alveolar-interstitial syndrome [5] and in the clinical management of critically ill patients [6] . In the specific context of COVID-19 pandemic, LUS has been well employed in the diagnostic stage [7] , and during the invasive ventilation support to monitor the evolution of aeration [8] . LUS features of COVID-19 pneumonia correspond with that obtained with the gold standard Computed Tomography, although the sensitivity and specificity remain to be determined [9] . The injured lung patterns vary from mild to severe interstitial pattern (patchy single to confluent B lines, waterfall or light beam [10] , white lung), to alveolar J o u r n a l P r e -p r o o f involvement with small and large consolidations that suggest hypo-ventilated or nonventilated parenchyma. Air-bronchogram expresses the aeration entity. Pleural effusion is uncommon. Lesions are generally distributed to the posterior, inferior and peripheral portions of the lung. We describe the management of four patients with COVID-19 pneumonia, confirmed by specific nasopharyngeal swab and by HRTC, admitted into our Sub-Intensive Care Unit, for underling the LUS added value to decision-making processes concerning medical treatment and to the management of non-invasive ventilation. Written informed consent was obtained from all patient. The sonographic examination was performed by a single experienced operator using a convex multifrequency transducer. Fourteen lung areas (3 posterior, 2 lateral and 2 anterior) were scanned per patient and was employed a lung severity score (LUS score) divided in three values (0 normal, 1 discontinuous pleural lines with B lines, 2 small consolidations or white lung, 3 large consolidations), with a minimum score of zero and maximum score of 42 [8] . Oxygen therapy is distinguished as low support when < 6 l/min and high support when ≥ 6 l/min. SpO2 target of any ventilation support was ≥ 95%. Clinical and laboratory data of patients are showed in table 1 and 2.

A 51-year-old man was admitted with two days history of symptoms. HRTC showed areas of crazy paving at both lungs. Ratio between arterial oxygen partial pressure and inspired oxygen fraction (FiO2) (P/F ratio) was 348 with low oxygen support. He was commenced on Hydroxychloroquine and thromboprophylaxis. Seven days after admission (day 9 since illness onset), LUS showed an evolution with diffuse B lines Considerations: LUS assisted in detecting early signs of worsening of lung pattern, and with worsening of P/F ratio, it helped in prompting decision making for the administration of immunomodulatory therapy and non-invasive ventilation support.

A 64-year-old woman was admitted with 8 days. HRCT showed a diffuse groundglass pattern. P/F ratio was 311 with low oxygen support. She was commenced on Hydroxychloroquine and thromboprophylaxis. Two days later (day 10 since illness onset) the patient worsened, with P/F of 100. Helmet CPAP (PEEP of 12 cmH20 and FiO2 up to 70%) was administered and Dexamethasone (20 mg q24h for 5 days) was prescribed. Four days later (day 14), the patient was shifted to high oxygen flow achieving a P/F of 240, but she was still complaining of dyspnea. LUS revealed diffuse interstitial involvement [ Fig. 2a] , with a large consolidation at the right lower lobe [ Fig. 2b ]. Pleural effusion with lobar atelectasis was found at the left lower lobe [ Fig. 2c ]. LUS score of 22 with pleural effusion. CPAP support continued, stopping it during meals. After four days (day 17), LUS revealed air-bronchogram signs within consolidations associated to a concurrent clinical and P/F improvement (P/F 276). LUS score of 24. Eight days after (day 25), the patient progressively became eupneic, consolidations showed reduction in size (right consolidation 66 x 21mm, left 24 x 30 mm) and increase in air-bronchogram ( Fig. 3c -Fig. 3d ). LUS score of 18. Monitoring of appearance of air-bronchogram and reduction in the extension of consolidations, confirmed evolution of re-aeration that correlates to disease progression and recovery.

A 70-year-old man presented with a four days history of fever. HRTC showed patchy ground glass. P/F was 184 with low oxygen flow. Hydroxychloroquine and thromboprophylaxis were started. Tocilizumab was administered and the patient was supported with CPAP (PEEP 10-12.5 cmH20, FiO2 up to 70%). Seven days after (day 15), diffuse B lines and patchy white lung pattern persisted, without appearance of consolidations (LUS score of 21) [ fig. 4c -Fig. 4d ] and stable P/F. PEEP was titrated until CPAP discontinuation and the patient's full recovery. Considerations: B-lines persistence, without worsening of degree (stable LUS score) with a stable P/F ratio, supported the decision to continue non-invasive ventilation and guided titration of the PEEP.

We purposed four main applications of LUS during the management of severe COVID-19 pneumonia in the Sub-Intensive Respiratory Unit. Case series on LUS employment in COVID-19 disease, have primarily explored the diagnostic phase and the intensive care phase [9] [11] [12] [13] . A monitoring role of LUS in the lung failure of COVID-19 in phase of Sub-Intensive care, is less investigated although its crucial role has been suggested [14] .

Based on the evidence that an early intervention is the key to success, the first case underlines the crucial monitoring role of LUS, that integrates clinical signs, vital parameters and arterial blood gases values, to allow early detection of the evolution to severe pneumonia. Indicatively, a first examination should be performed within seven days from the illness onset or in case of clinical worsening. In the second and fourth case, we showed the use of ultrasound to help in guiding the management of non-invasive ventilation, with CPAP helping to avoid intubation [15] . In COVID-19 pneumonia, hypoxia is due to ventilation-perfusion mismatch or intrapulmonary shunting [16] , attempts at finding the optimal respiratory treatment protocol are widely discussed [17] . CT scan can detect and quantify the changes in the degree of pulmonary aeration but also LUS has been applied for this purpose in critically ill patients with ARDS [18] , and it has been proposed for this evaluation in COVID-19 pneumonia [19] . Despite its high performance, for close monitoring of COVID-19 pneumonia patients, CT scan monitoring is unadvisable, due to the intrinsic biological risk, both in terms of infection control and increased radiation to the patient, while LUS looks like a compelling alternative and has been described to have high rates of sensitivity and specificity in assisting the clinician during diagnosis of the acute respiratory phase [20] . An algorithm has been proposed to combine ultrasound features of mild to severe patters, with respiratory rate and oxygenation index, to determining the requirement for intubation of COVID-19 patients with acute respiratory failure [13] . During mechanical ventilatory support and its weaning [21] , LUS examination showed lung re-aeration mostly by the disappearance of B lines, as guide to the PEEP titration [22] , and an ultrasound re-aeration score is validated [23] . The reduction in B lines, the resolution of consolidations or air-bronchogram reappearance suggest an improvement of respiratory gas exchange.

The monitoring of LUS features of aeration could guide CPAP treatment, by adjusting CPAP weaning time. This is useful to improve the patient's compliance to noninvasive ventilation, preventing the alveolar de-recruitment after CPAP suspension and leading to a gradual reduction in PEEP values. This requires serial LUS examinations, almost every 2-3 days, preferably not during CPAP support. The third case underlines the utility of LUS in a qualitative monitoring of size of consolidations, and presence/absence of air-bronchogram. Clinical recovery usually comes before the complete resolution of lesions but the occurrence and enhancement of the air-bronchogram and the progressive shrinking of consolidations are signs of the improvement. The bidimensional shape of consolidations has a partial correspondence to their volume but it may suggest their evolution as well as may represent common lesions [5] . We suggest this assessment of consolidations every 4-7 days. We chose one [8] of the proposed severity lung scores for COVID-19 pneumonia [24] [25] which divides the lungs in 14 areas examined. We found it useful to allowing a better anatomical localization of pulmonary lesions when the back of patient is explorable, because the lesions have a typical posterior and gravitational position. However, the known LUS assessment in 12 regions remains as well accurate [26] .

Combining the severity score with information regarding the presence of pleural effusion, atelectasis and a qualitative evaluation of consolidations, could give relevant information about illness evolution. LUS evaluation has however some limitations in this context. Ultrasound lacks the panoramic vision, consolidations cannot rule out the coexistence of embolisms [27] , although it has been described that Contrast-Enhanced Ultrasound may be of assistance [28] . Furthermore, LUS is operator dependent and it still lacks of a standardized anatomic evaluation as well as an ultrasound re-aeration score is not validated for non-invasive ventilation and LUS may underestimated lung recruitment. Prospective data with larger sample size that can be related to outcomes and management will be useful to explore these purposes of LUS employment in non-invasive ventilation therapy.

In severe COVID-19 pneumonia, LUS findings combined to clinical and arterial blood gases parameters, may be an important aid, in supporting the decision-making process, prompting timely intervention and tailoring non-invasive ventilation therapy.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

Severe Covid-19

COVID-19 Illness in native and immunosuppressed states: a clinical-therapeutic staging proposal

Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Ultrasound in the management of thoracic disease

Lung ultrasound in acute respiratory distress syndrome and acute lung injury

What's new in lung ultrasound during the COVID-19 pandemic

Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19

Chinese Cricital Care Ultrasound Study. Findings of lung ultrasonography of novel coronavirus pneumonia during the 2019-2020 epidemic

Sonographic signs and patterns of COVID-19 Pneumonia

A Preliminary Study on the Ultrasonic Manifestations of Peripulmonary Lesions of Non-Critical Novel Coronavirus Pneumonia (COVID-19)

COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review

A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure

Point-of-care lung ultrasound in patients with COVID-19-a narrative review

Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two period retrospective case-control study

Basing Respiratory Management of Coronavirus on Physiological Principles

COVID-19 pneumonia: different respiratory treatments for differents phenotypes?

Bedside Ultrasound assessement of positive end-expiratory pressure-induced lung recruitment

Application of Lung Ultrasound During the Coronavirus Disease 2019 Pandemic: A Narrative Review

Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure. The BLUE Protocol

Ultrasonography Evaluation During the Weaning Process: The Heart, the Diaphragm, the Pleura and the Lung

Bedside Ultrasound assessement of positive end-expiratory pressure-induced lung recruitment

Ultrasound Assessment of Antibiotic-Induced Pulmonary Reaeration in Ventilator-Associated Pneumonia

Prima linea Covid-19 Ecografia in urgenza

FOCUSED LUNG & CARDIAC POCUS EXAM in COVID-19, South TX Veterans Health Care System and University of Texas Health San Antonio

International evidence-based recommendations for pointof-care lung ultrasound

Are subpleural consolidations indicators for segmental pulmonary embolism in COVID-19?

Contrast-Enhanced Ultrasound in patients with COVID-19: pneumonia, acute respiratory distress syndrome, or something else?

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f